Brant Point Investment Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,936	Closed	-$2.82M	–	108
2023 Q4	$2.82M	Buy	11,936 +1,385	+13%	+$272K	0.67%	79
2023 Q3	$2.07M	Sell	10,551 -3,586	-25%	-$736K	0.49%	81
2023 Q2	$2.97M	Sell	14,137 -46	-0.3%	-$9.15K	0.68%	55
2023 Q1	$2.86M	Sell	14,183 -5,098	-26%	-$1.16M	0.68%	64
2022 Q4	$4.2M	Sell	19,281 -2,317	-11%	-$506K	1.19%	45
2022 Q3	$4.25M	Buy	21,598 +6,500	+43%	+$1.4M	1.1%	48
2022 Q2	$3.23M	Sell	15,098 -6,902	-31%	-$1.69M	0.79%	56
2022 Q1	$6.25M	Buy	22,000 +6,904	+46%	+$2.13M	1.29%	41
2021 Q4	$5.69M	Buy	15,096 +48	+0.3%	+$18.6K	1.05%	47
2021 Q3	$6.21M	Buy	15,048 +48	+0.3%	+$19.9K	1.15%	39
2021 Q2	$5.55M	Hold	15,000	–	–	0.96%	53
2021 Q1	$4.35M	Hold	15,000	–	–	0.79%	71
2020 Q4	$3.75M	Buy	15,000 +10,000	+200%	+$2.38M	0.73%	75
2020 Q3	$1.13M	Hold	5,000	–	–	0.22%	116
2020 Q2	$872K	Buy	+5,000	New	+$798K	0.19%	112
2019 Q2	–	Sell	-19,800	Closed	-$2.88M	–	120
2019 Q1	$2.88M	Buy	+19,800	New	+$2.6M	0.66%	70
2017 Q4	–	Sell	-38,800	Closed	-$4.19M	–	142
2017 Q3	$4.19M	Sell	38,800 -10,600	-21%	-$1.09M	0.8%	61
2017 Q2	$5M	Sell	49,400 -18,700	-27%	-$1.72M	0.96%	48
2017 Q1	$6.13M	Buy	+68,100	New	+$5.78M	1.17%	38